Wells Fargo & Company Lexaria Bioscience Corp. Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Wells Fargo & Company holds 4,000 shares of LEXX stock, worth $5,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,000
Previous 2,500
60.0%
Holding current value
$5,600
Previous $7,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding LEXX
# of Institutions
27Shares Held
1.49MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY460KShares$644,0000.01% of portfolio
-
Invenomic Capital Management LP Boston, MA411KShares$575,0230.04% of portfolio
-
Geode Capital Management, LLC Boston, MA167KShares$233,3500.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA127KShares$178,4060.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL60.6KShares$84,8960.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $8.33M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...